Refractory overactive bladder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged >= 18 years; 2. Patients with overactive bladder (OAB) symptoms, such as urgent urinary incontinence, frequent urination and urgency, who have been implanted with sacral nerve stimulation system; 3. The patients who agreed not to increase or decrease the drugs related to lower urinary tract symptoms and pelvic function during the trial; 4. Patients who voluntarily participate in clinical trials and can sign informed consent form; 5. Subjects who can communicate well with researchers and are willing to comply with the requirements of the whole experiment.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Patients with uncontrolled urinary tract infection, urinary tract obstruction and urinary tract tumor; 3. Patients with mental disorders who cannot cooperate with doctors; 4. Patients with non urinary malignancies and other concomitant diseases that seriously affect their health; 5. Patients who have received botulinum toxin treatment in the past 12 months; 6. Patients with severe pelvic organ prolapse; 7. Patients who have participated in other clinical trials 3 months before the trial; 8. Other situations in which the researcher considers it inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic efficiency; | — |
Secondary
| Measure | Time frame |
|---|---|
| OABSS;QOL;VAS scores;satisfaction; | — |
Countries
China
Contacts
Beijing Hospital